{"id":"https://openalex.org/W2069640261","doi":"https://doi.org/10.1016/s1262-3636(13)71659-8","title":"O47 Chez des patients diab\u00e9tiques de type 2, l\u2019antagoniste du r\u00e9cepteur du glucagon LY2409021 diminue significativement l\u2019HbA1c et est bien tol\u00e9r\u00e9 apr\u00e8s 12 semaines de traitement","display_name":"O47 Chez des patients diab\u00e9tiques de type 2, l\u2019antagoniste du r\u00e9cepteur du glucagon LY2409021 diminue significativement l\u2019HbA1c et est bien tol\u00e9r\u00e9 apr\u00e8s 12 semaines de traitement","publication_year":2013,"publication_date":"2013-03-01","ids":{"openalex":"https://openalex.org/W2069640261","doi":"https://doi.org/10.1016/s1262-3636(13)71659-8","mag":"2069640261"},"language":"fr","primary_location":{"id":"doi:10.1016/s1262-3636(13)71659-8","doi":"https://doi.org/10.1016/s1262-3636(13)71659-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1262-3636(13)71659-8","pdf_url":null,"source":{"id":"https://openalex.org/S49871393","display_name":"Diabetes & Metabolism","issn_l":"1262-3636","issn":["1262-3636","1878-1780"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes &amp; Metabolism","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044354749","display_name":"C. Bonnard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Bonnard","raw_affiliation_strings":["Eli Lilly and Compagny, Neuilly sur Seine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Compagny, Neuilly sur Seine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085855526","display_name":"CHRISTOF M. KAZDA","orcid":"https://orcid.org/0000-0002-2538-2573","observed_orcids":["https://orcid.org/0000-0002-2538-2573"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Kazda","raw_affiliation_strings":["Eli Lilly and Compagny, Neuilly sur Seine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Compagny, Neuilly sur Seine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020212376","display_name":"Parag Garhyan","orcid":"https://orcid.org/0009-0009-8741-2115","observed_orcids":["https://orcid.org/0009-0009-8741-2115"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Garhyan","raw_affiliation_strings":["Eli Lilly and Compagny, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Compagny, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R.P. Kelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101515","display_name":"Eli Lilly (Singapore)","ror":"https://ror.org/010ajwv03","country_code":"SG","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210101515"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"R.P. Kelly","raw_affiliation_strings":["Eli Lilly and Compagny, Singapour Singapour"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Compagny, Singapour Singapour","institution_ids":["https://openalex.org/I4210101515"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Shi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Shi","raw_affiliation_strings":["Pharmanet/i3, Ellicott City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmanet/i3, Ellicott City, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Ngee Lim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101515","display_name":"Eli Lilly (Singapore)","ror":"https://ror.org/010ajwv03","country_code":"SG","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210101515"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"C. Ngee Lim","raw_affiliation_strings":["Eli Lilly and Compagny, Singapour Singapour"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Compagny, Singapour Singapour","institution_ids":["https://openalex.org/I4210101515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069556286","display_name":"Haoda Fu","orcid":"https://orcid.org/0000-0002-0538-4651","observed_orcids":["https://orcid.org/0000-0002-0538-4651"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Fu","raw_affiliation_strings":["Eli Lilly and Compagny, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Compagny, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057449551","display_name":"Mark A. Deeg","orcid":"https://orcid.org/0000-0001-6920-9396","observed_orcids":["https://orcid.org/0000-0001-6920-9396"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Deeg","raw_affiliation_strings":["Eli Lilly and Compagny, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Compagny, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4490,"currency":"USD","value_usd":4490},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":null,"first_page":"A12","last_page":"A12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7879999876022339},{"id":"https://openalex.org/keywords/glucagon-receptor-antagonists","display_name":"glucagon receptor antagonists","score":0.9800000190734863},{"id":"https://openalex.org/keywords/hba1c-reduction","display_name":"HbA1c reduction","score":0.8740000128746033},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8769999742507935},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7369999885559082},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.4009999930858612},{"id":"https://openalex.org/keywords/liver-enzymes","display_name":"liver enzymes","score":0.4519999921321869},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.7549999952316284},{"id":"https://openalex.org/keywords/fasting-insulin","display_name":"fasting insulin","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.435075581073761},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39447930455207825},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33657121658325195},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11473116278648376}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1262-3636(13)71659-8","doi":"https://doi.org/10.1016/s1262-3636(13)71659-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1262-3636(13)71659-8","pdf_url":null,"source":{"id":"https://openalex.org/S49871393","display_name":"Diabetes & Metabolism","issn_l":"1262-3636","issn":["1262-3636","1878-1780"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes &amp; Metabolism","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2319465471","https://openalex.org/W2207556001","https://openalex.org/W2079920392","https://openalex.org/W2532504933","https://openalex.org/W2790331918","https://openalex.org/W2325334512","https://openalex.org/W2600127085","https://openalex.org/W2789382669","https://openalex.org/W2281267627","https://openalex.org/W2793599820"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}
